Cachet Pharmaceutical Co., Ltd. (002462.SZ)
CNY 13.73
(-0.94%)
CNY 13.73
(-0.94%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.56 Billion CNY | -4.85% |
| 2022 | 2.69 Billion CNY | 23.19% |
| 2021 | 2.18 Billion CNY | 8.53% |
| 2020 | 2.01 Billion CNY | -10.64% |
| 2019 | 2.25 Billion CNY | 30.71% |
| 2018 | 1.72 Billion CNY | 29.02% |
| 2017 | 1.33 Billion CNY | 13.13% |
| 2016 | 1.18 Billion CNY | 25.53% |
| 2015 | 940.79 Million CNY | 40.21% |
| 2014 | 670.98 Million CNY | 49.03% |
| 2013 | 450.23 Million CNY | 98.29% |
| 2012 | 227.05 Million CNY | 76.3% |
| 2011 | 128.79 Million CNY | -32.7% |
| 2010 | 191.37 Million CNY | 70.53% |
| 2009 | 112.21 Million CNY | 12.85% |
| 2008 | 99.44 Million CNY | 2.32% |
| 2007 | 97.18 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.61 Billion CNY | 2.17% |
| 2024 Q3 | 2.67 Billion CNY | 4.17% |
| 2024 Q2 | 2.56 Billion CNY | -1.97% |
| 2023 Q4 | 2.56 Billion CNY | -0.44% |
| 2023 Q2 | 2.67 Billion CNY | 1718763.43% |
| 2023 FY | 2.56 Billion CNY | -4.85% |
| 2023 Q3 | 2.57 Billion CNY | -3.98% |
| 2023 Q1 | -155.91 Thousand CNY | -100.01% |
| 2022 Q2 | 2.65 Billion CNY | 9.59% |
| 2022 Q3 | 2.66 Billion CNY | 0.1% |
| 2022 FY | 2.69 Billion CNY | 23.19% |
| 2022 Q4 | 2.69 Billion CNY | 1.18% |
| 2022 Q1 | 2.42 Billion CNY | 10.99% |
| 2021 Q3 | 2.1 Billion CNY | -5.17% |
| 2021 Q4 | 2.18 Billion CNY | 3.69% |
| 2021 Q1 | 2.31 Billion CNY | 14.9% |
| 2021 FY | 2.18 Billion CNY | 8.53% |
| 2021 Q2 | 2.22 Billion CNY | -3.93% |
| 2020 Q3 | 2.42 Billion CNY | 3.7% |
| 2020 Q1 | 2.45 Billion CNY | 9.09% |
| 2020 Q4 | 2.01 Billion CNY | -17.08% |
| 2020 Q2 | 2.34 Billion CNY | -4.74% |
| 2020 FY | 2.01 Billion CNY | -10.64% |
| 2019 Q3 | 1.93 Billion CNY | 1.3% |
| 2019 Q1 | 1.95 Billion CNY | 13.5% |
| 2019 Q4 | 2.25 Billion CNY | 16.4% |
| 2019 FY | 2.25 Billion CNY | 30.71% |
| 2019 Q2 | 1.91 Billion CNY | -2.34% |
| 2018 Q2 | 1.59 Billion CNY | -6.04% |
| 2018 Q1 | 1.7 Billion CNY | 27.42% |
| 2018 FY | 1.72 Billion CNY | 29.02% |
| 2018 Q3 | 1.77 Billion CNY | 10.75% |
| 2018 Q4 | 1.72 Billion CNY | -2.69% |
| 2017 Q2 | 1.26 Billion CNY | 5.02% |
| 2017 FY | 1.33 Billion CNY | 13.13% |
| 2017 Q4 | 1.33 Billion CNY | -3.55% |
| 2017 Q3 | 1.38 Billion CNY | 9.46% |
| 2017 Q1 | 1.2 Billion CNY | 2.03% |
| 2016 Q4 | 1.18 Billion CNY | 2.35% |
| 2016 Q1 | 985.9 Million CNY | 4.79% |
| 2016 Q2 | 1.07 Billion CNY | 9.03% |
| 2016 FY | 1.18 Billion CNY | 25.53% |
| 2016 Q3 | 1.15 Billion CNY | 7.34% |
| 2015 Q3 | 881.8 Million CNY | 24.64% |
| 2015 FY | 940.79 Million CNY | 40.21% |
| 2015 Q1 | 707.18 Million CNY | 5.39% |
| 2015 Q4 | 940.79 Million CNY | 6.69% |
| 2015 Q2 | 707.49 Million CNY | 0.04% |
| 2014 Q1 | 441.35 Million CNY | -1.97% |
| 2014 FY | 670.98 Million CNY | 49.03% |
| 2014 Q4 | 670.98 Million CNY | 9.35% |
| 2014 Q3 | 613.6 Million CNY | 7.47% |
| 2014 Q2 | 570.94 Million CNY | 29.36% |
| 2013 FY | 450.23 Million CNY | 98.29% |
| 2013 Q2 | 261.3 Million CNY | -0.21% |
| 2013 Q3 | 364.6 Million CNY | 39.53% |
| 2013 Q1 | 261.84 Million CNY | 15.32% |
| 2013 Q4 | 450.23 Million CNY | 23.48% |
| 2012 Q3 | 240.58 Million CNY | -0.44% |
| 2012 Q1 | 176.49 Million CNY | 37.04% |
| 2012 Q2 | 241.64 Million CNY | 36.91% |
| 2012 Q4 | 227.05 Million CNY | -5.62% |
| 2012 FY | 227.05 Million CNY | 76.3% |
| 2011 Q3 | 178.26 Million CNY | 5.43% |
| 2011 FY | 128.79 Million CNY | -32.7% |
| 2011 Q4 | 128.79 Million CNY | -27.75% |
| 2011 Q1 | 159.69 Million CNY | -16.55% |
| 2011 Q2 | 169.08 Million CNY | 5.88% |
| 2010 FY | 191.37 Million CNY | 70.53% |
| 2010 Q4 | 191.37 Million CNY | 24.13% |
| 2010 Q3 | 154.16 Million CNY | 18.66% |
| 2010 Q2 | 129.92 Million CNY | 0.0% |
| 2009 FY | 112.21 Million CNY | 12.85% |
| 2009 Q4 | 112.21 Million CNY | 0.0% |
| 2008 FY | 99.44 Million CNY | 2.32% |
| 2007 FY | 97.18 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Yixintang Pharmaceutical Group Co., Ltd. | 3.85 Billion CNY | 33.506% |
| ZJAMP Group Co., Ltd. | 5.96 Billion CNY | 57.031% |
| Luyan Pharma Co.,Ltd. | 2.57 Billion CNY | 0.481% |
| Ji Yao Holding Group Co., Ltd. | 116.44 Million CNY | -2100.011% |